SCHEMBL19923487

SCHEMBL19923487

C[Si](C)(C)N1C(=O)N(Cc2ccccc2)C(c2ccccc2)(c2ccccc2)C1=O

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ELANE P08246 4/20 0.41
NPSR1 Q6W5P4 3/20 0.41
ALDH1A1 P00352 1/20 0.40
CTSG P08311 2/20 0.40
PRTN3 P24158 1/20 0.40
CYP2C19 P33261 3/20 0.40
F2 P00734 1/20 0.40
PLG P00747 1/20 0.40
CMA1 P23946 1/20 0.40
CTRC Q99895 1/20 0.40
HTR1A P08908 2/20 0.38
HTR7 P34969 2/20 0.38
HTR6 P50406 2/20 0.38
OPRM1 P35372 1/20 0.36
OPRL1 P41146 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM3 P20309 1/20 0.36
KDM4E B2RXH2 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19923625 0.86 NPSR1 (0.42) ELANENPSR1ALDH1A1CTSGPRTN3
SCHEMBL19923716 0.85 BACE1 (0.40) ELANENPSR1ALDH1A1CYP2C19HTR1A
SCHEMBL19923618 0.85 NPSR1 (0.41) ELANENPSR1ALDH1A1CTSGPRTN3
SCHEMBL19923500 0.84 ELANE (0.39) ELANENPSR1ALDH1A1CTSGCYP2C19
SCHEMBL19923637 0.84 ELANE (0.44) ELANENPSR1ALDH1A1CTSGPRTN3
SCHEMBL19923521 0.82 ELANE (0.47) ELANENPSR1ALDH1A1CTSGPRTN3
SCHEMBL19923720 0.82 NPSR1 (0.44) ELANENPSR1ALDH1A1CTSGPRTN3
SCHEMBL19923621 0.79 NPSR1 (0.51) ELANENPSR1ALDH1A1CTSGPRTN3
SCHEMBL19923635 0.78 ELANE (0.53) ELANENPSR1CTSGPRTN3CYP2C19
SCHEMBL14372430 0.78 NPSR1 (0.49) ELANENPSR1ALDH1A1CTSGPRTN3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US claimed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US claimed
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US disclosed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS PARG, HNMT, PARN ELANE 1249/4885NPSR1 1322/4885ALDH1A1 2648/4885
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds HNMT, PARG, PAM ELANE 1276/4885NPSR1 1281/4885ALDH1A1 2554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.